Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Shares Issued (2016 - 2024)

Utah Medical Products (UTMD) has 15 years of Shares Issued data on record, last reported at $294000.0 in Q2 2024.

  • For Q2 2024, Shares Issued rose 390.0% year-over-year to $294000.0; the TTM value through Mar 2025 reached $294000.0, up 53.12%, while the annual FY2024 figure was $390000.0, 233.33% up from the prior year.
  • Shares Issued reached $294000.0 in Q2 2024 per UTMD's latest filing, up from $96000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $294000.0 in Q2 2024 and bottomed at $3000.0 in Q2 2021.
  • Average Shares Issued over 5 years is $94058.8, with a median of $60000.0 recorded in 2023.
  • Peak YoY movement for Shares Issued: plummeted 90.32% in 2021, then surged 1400.0% in 2023.
  • A 5-year view of Shares Issued shows it stood at $76000.0 in 2020, then soared by 267.11% to $279000.0 in 2021, then crashed by 53.05% to $131000.0 in 2022, then tumbled by 72.52% to $36000.0 in 2023, then soared by 716.67% to $294000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $294000.0 in Q2 2024, $96000.0 in Q1 2024, and $36000.0 in Q3 2023.